Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2025-12-25 @ 10:08 PM
NCT ID: NCT01468558
Description: All 24 subjects who received MAP0004 alone, 24 subjects who received MAP0004 with ketoconazole, and 22 subjects who received IV DHE are included in the adverse event analysis. Adverse events are presented by treatment arm, not necessarily by individual treatment (intervention) received.
Frequency Threshold: 5
Time Frame: None
Study: NCT01468558
Study Brief: Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
MAP0004 1.0mg MAP0004 1.0mg via inhalation on Day 1 of Visit 2. None None 0 24 6 24 View
MAP0004 1.0mg + Ketoconazole Ketoconazole 400mg once a day on Days 3-6 of Visit 2 and MAP0004 1.0mg via inhalation on Day 6 of Visit 2. None None 0 24 7 24 View
IV DHE 1.0mg IV DHE 1.0mg on Day 1 of Visit 3. None None 0 22 11 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (11.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (11.1) View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (11.1) View
Hot flush SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (11.1) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (11.1) View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (11.1) View